Article

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9:88

Centre for Health Evaluation and Outcome Sciences, St Paul's Hospital, BC, Canada.
BMC Public Health (Impact Factor: 2.32). 04/2009; 9(1):88. DOI: 10.1186/1471-2458-9-88
Source: PubMed

ABSTRACT Overweight and obese persons are at risk of a number of medical conditions which can lead to further morbidity and mortality. The primary objective of this study is to provide an estimate of the incidence of each co-morbidity related to obesity and overweight using a meta-analysis.
A literature search for the twenty co-morbidities identified in a preliminary search was conducted in Medline and Embase (Jan 2007). Studies meeting the inclusion criteria (prospective cohort studies of sufficient size reporting risk estimate based on the incidence of disease) were extracted. Study-specific unadjusted relative risks (RRs) on the log scale comparing overweight with normal and obese with normal were weighted by the inverse of their corresponding variances to obtain a pooled RR with 95% confidence intervals (CI).
A total of 89 relevant studies were identified. The review found evidence for 18 co-morbidities which met the inclusion criteria. The meta-analysis determined statistically significant associations for overweight with the incidence of type II diabetes, all cancers except esophageal (female), pancreatic and prostate cancer, all cardiovascular diseases (except congestive heart failure), asthma, gallbladder disease, osteoarthritis and chronic back pain. We noted the strongest association between overweight defined by body mass index (BMI) and the incidence of type II diabetes in females (RR = 3.92 (95% CI: 3.10-4.97)). Statistically significant associations with obesity were found with the incidence of type II diabetes, all cancers except esophageal and prostate cancer, all cardiovascular diseases, asthma, gallbladder disease, osteoarthritis and chronic back pain. Obesity defined by BMI was also most strongly associated with the incidence of type II diabetes in females (12.41 (9.03-17.06)).
Both overweight and obesity are associated with the incidence of multiple co-morbidities including type II diabetes, cancer and cardiovascular diseases. Maintenance of a healthy weight could be important in the prevention of the large disease burden in the future. Further studies are needed to explore the biological mechanisms that link overweight and obesity with these co-morbidities.

Download full-text

Full-text

Available from: Laird Birmingham, Jun 03, 2014
4 Followers
 · 
208 Views
  • Source
    • "Diabetes and obesity are serious health threats and increase the risk for many chronic diseases. The World Health Organization predicts that 3 billion adults will be either overweight or obese by 2015 [1]. Obesity is one of the strongest risk factors for the development of type 2 diabetes [2]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes and obesity are worldwide health problems. White fat dynamically participates in hormonal and inflammatory regulation. White adipose tissue is recognized as a multifactorial organ that secretes several adipose-derived factors that have been collectively termed " adipokines. " Adipokines are pleiotropic molecules that gather factors such as leptin, adiponectin, visfatin, apelin, vaspin, hepcidin, RBP4, and inflammatory cytokines, including TNF and IL-1í µí»½, among others. Multiple roles in metabolic and inflammatory responses have been assigned to these molecules. Several adipokines contribute to the self-styled " low-grade inflammatory state " of obese and insulin-resistant subjects, inducing the accumulation of metabolic anomalies within these individuals, including autoimmune and inflammatory diseases. Thus, adipokines are an interesting drug target to treat autoimmune diseases, obesity, insulin resistance, and adipose tissue inflammation. The aim of this review is to present an overview of the roles of adipokines in different immune and nonimmune cells, which will contribute to diabetes as well as to adipose tissue inflammation and insulin resistance development. We describe how adipokines regulate inflammation in these diseases and their therapeutic implications. We also survey current attempts to exploit adipokines for clinical applications, which hold potential as novel approaches to drug development in several immune-mediated diseases.
    Journal of Diabetes Research 04/2015; 2014:11. DOI:10.1155/2015/681612 · 3.54 Impact Factor
  • Source
    • "Obesity is recognized as a major public health problem, and its prevalence is increasing rapidly in westernized countries [6] [7]. Obese individuals are at higher risk of developing a wide spectrum of chronic diseases such as diabetes , cardiovascular disease, cancer, and musculoskeletal disorders, such as spinal problems [8]. Body weight, an important factor related to spinal loading, has been associated with several signs of lumbar disc degeneration (LDD), including disc space narrowing [9] and decreased signal intensity of the lumbar intervertebral discs [10]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The relationships between obesity and both low back pain (LBP) and lumbar disc degeneration (LDD) remain unclear. It is possible that familial factors, including genetics and early environment, affect these relationships.
    The Spine Journal 02/2015; 15(5). DOI:10.1016/j.spinee.2015.02.001 · 2.80 Impact Factor
  • Source
    • "diabetes) 8 . While underweight indicates potentially poor nutrition and sickness, it is well recognized that significant overweight is associated with diabetes, many forms of cancer, cardiovascular diseases, asthma and other diseases (Guh et al., 2009). As poor individuals are often thought of as maximizing calories given their budget (cf. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Increasing labor migration and simultaneous aging of societies are two impor-tant demographic developments many poor countries face. Elderly people who are left behind may experience a decrease in welfare when their children migrate. This paper investigates the effect of migration on various dimensions of elderly health using unique data from Moldova, which has one of the highest emigration rates in the world. We find positive migration effects on body mass index (BMI), mobility and self-reported health. No effects are found on depression and cognitive capac-ity. We find evidence that these positive outcomes are linked to an income effect which leads to improvements in diet and identify a reallocation of time use from subsistence farming to leisure and sleep which may have further beneficial effects. These positive effects seem to compensate the elderly for decreasing social contact with their migrant family members. For final version please see journal article. Free download until February 28, 2015: http://authors.elsevier.com/a/1QLIec7LFcAlt
    Journal of Health Economics 01/2015; 39(January):211–227. DOI:10.1016/j.jhealeco.2014.09.001 · 2.25 Impact Factor
Show more